摘要
目的:本综述旨在研究与 COVID-19 感染最相关的受体家族和功能,并提出大多数 COVID-19 受体主要表达的组织和细胞位置。 方法:本系统评价是根据 PRISMA 指南进行的。使用了 PubMed、Cochrane、SciELO、Lilacs、Web of Science 和 DOAJ 数据库。本综述纳入了研究 COVID-19 相关受体的临床试验和研究文章。采用R编程语言编制图表和受体网络,采用SPSS(26v)软件进行统计分析(PROSPERO:CRD42020210643)。 结果:大多数关于受体参与 COVID-19 的研究包括血浆受体和 G 蛋白偶联受体家族(p<0.05)。这些受体在大脑中高度表达(24%),其中 80% 可以在蛋白质网络中相互作用,对各种组织发挥一定的调节作用。在参与 COVID-19 的受体网络中,主要有影响的受体是 EGFR,大多数受体与疾病的病理过程有关(p<0.05),包括 COVID-19 中炎症反应的放大,这可能在某些情况下与神经系统疾病有关。对参与 COVID-19 的受体的研究主要包括来自美国、西班牙和巴西的患者(p<0.05)。 结论:血浆受体和 G 蛋白偶联受体,尤其是 EGFR,参与 COVID-19 脑炎症过程的病理作用,在本综述中显示出重要意义。
关键词: 脑、COVID-19、表皮生长因子受体、G 蛋白偶联受体、炎症、血浆受体。
Current Medicinal Chemistry
Title:The Main Receptors Involved in the COVID-19: A Systematic Review and Meta-Analysis
Volume: 28 Issue: 34
关键词: 脑、COVID-19、表皮生长因子受体、G 蛋白偶联受体、炎症、血浆受体。
摘要:
Objective: This review aims to study the receptor's family and functions most related to COVID-19 infection and also suggest the tissue and cell location on which the majority of COVID-19 receptors are mainly expressed.
Methods: This systematic review is according to PRISMA guidelines. PubMed, Cochrane, SciELO, Lilacs, Web of Science, and DOAJ databases were used. Clinical trials and research articles studying receptors related to COVID-19 were included in this review. R programming language was used to elaborate charts and receptors network, and SPSS(26v) software was used to perform statistical analysis (PROSPERO: CRD42020210643).
Results: The majority of studies on the involvement of receptors in COVID-19 included plasma receptors and G protein-coupled receptor families (p<0.05). These receptors are highly expressed in the brain (24%) and 80% of them can interact with each other in a protein network, exerting some regulatory effects on various tissues. The main influential receptor in the network of receptors involved in the COVID-19 was the EGFR and the majority of receptors were associated with pathological processes of the disease (p<0.05), including the amplification of inflammatory responses in COVID-19, which may be related to neurological disorders in some cases. Studies on receptors involved in the COVID-19 included mainly patients from the United States, Spain, and Brazil (p<0.05).
Conclusion: Plasma receptors and G protein-coupled receptors, especially the EGFR, involved in pathological effects of the COVID-19 inflammatory process in the brain have shown significant importance in this review.
Export Options
About this article
Cite this article as:
The Main Receptors Involved in the COVID-19: A Systematic Review and Meta-Analysis, Current Medicinal Chemistry 2021; 28 (34) . https://dx.doi.org/10.2174/0929867328666210405113253
DOI https://dx.doi.org/10.2174/0929867328666210405113253 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Roles of MicroRNAs in Atherosclerosis
Current Medicinal Chemistry Molecular Determinants of the Cardiometabolic Phenotype
Endocrine, Metabolic & Immune Disorders - Drug Targets Toxins Targeting Voltage-Activated Ca<sup>2+</sup> Channels and their Potential Biomedical Applications
Current Topics in Medicinal Chemistry Functional Link Between Adenosine and Insulin: A Hypothesis for Fetoplacental Vascular Endothelial Dysfunction in Gestational Diabetes
Current Vascular Pharmacology Specific Immune Intervention with Monoclonal Antibodies for the Treatment of Multiple Sclerosis
Current Medicinal Chemistry Molecular Genetics of Abdominal Aortic Aneurysm: Therapeutic Implications
Current Pharmacogenomics and Personalized Medicine Insulin Like Growth Factor-I: A Critical Mediator of the Skeletal Response to Parathyroid Hormone
Current Molecular Pharmacology Jun Dimerization Protein 2 in Oxygen Restriction; Control of Senescence
Current Pharmaceutical Design Dietary Intake in HIV-Infected Men with Lipodystrophy: Relationships with Body Composition, Visceral Fat, Lipid, Glucose and Adipokine Metabolism
Current HIV Research A Partial Failure of Membrane Protein Turnover May Cause Alzheimers Disease: A New Hypothesis
Current Alzheimer Research Delivering RNA Interference to the Mammalian Brain
Current Gene Therapy Impulse Control Disorders in Parkinson’s Disease: A Review
Current Psychiatry Reviews Nanoparticles, Neurotoxicity and Neurodegenerative Diseases
Current Drug Metabolism Cannabinoids: Occurrence and Medicinal Chemistry
Current Medicinal Chemistry Recent Developments in Group I Metabotropic Glutamate Receptor Allosteric Modulators for the Treatment of Psychiatric and Neurological Disorders (2014-May 2015)
Current Topics in Medicinal Chemistry The Emerging Role of Bcr-Abl-Induced Cystoskeletal Remodeling in Systemic Persistence of Leukemic Stem Cells
Current Drug Delivery Micro Arrays and Biochips: Applications and Potential in Genomics and Proteomics
Current Genomics A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody Response in Rabbits and Nonhuman Primates
Current Gene Therapy Advances in Anticancer Antibody-Drug Conjugates and Immunotoxins
Recent Patents on Anti-Cancer Drug Discovery Safety and Efficacy of Immune Checkpoint Inhibitors in Children and Young Adults with Haematological Malignancies: Review and Future Perspectives
Cardiovascular & Hematological Agents in Medicinal Chemistry